# 4D Molecular Therapeutics, Inc.: Form 8-K, filed Dec 11, 2024

- Company: [4D Molecular Therapeutics, Inc.](/companies/fdmt.md) (CIK 1650648)
- Form: 8-K
- Filed: 2024-12-11
- Accepted by EDGAR: Dec 11, 2024, 21:15 ET
- Period: 2024-12-06
- Accession: 0000950170-24-135381
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1650648/000095017024135381/fdmt-20241206.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650648/000095017024135381/

## Items reported

- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650648/000095017024135381/fdmt-20241206.htm

Filed Dec 11, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-135381. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.